Your search returned 2 results.

Results
	1.	Pazopanib in pretreated advanced neuroendocrine tumors: a phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE). [electronic resource] by Grande, E Capdevila, J Castellano, D Teulé, A Durán, I Fuster, J Sevilla, I Escudero, P Sastre, J García-Donas, J Casanovas, O Earl, J Ortega, L Apellaniz-Ruiz, M Rodriguez-Antona, C Alonso-Gordoa, T Díez, J J Carrato, A García-Carbonero, R Producer: 20160609 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	High frequency and founder effect of the CYP3A4*20 loss-of-function allele in the Spanish population classifies CYP3A4 as a polymorphic enzyme. [electronic resource] by Apellániz-Ruiz, M Inglada-Pérez, L Naranjo, M E G Sánchez, L Mancikova, V Currás-Freixes, M de Cubas, A A Comino-Méndez, I Triki, S Rebai, A Rasool, M Moya, G Grazina, M Opocher, G Cascón, A Taboada-Echalar, P Ingelman-Sundberg, M Carracedo, A Robledo, M Llerena, A Rodríguez-Antona, C Producer: 20160210 In: The pharmacogenomics journal vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search